Mazess Richard B, Bischoff-Ferrari Heike A, Dawson-Hughes Bess
Department of Medical Physics University of Wisconsin Madison WI USA.
Department of Aging Medicine and Aging Research University of Zurich Zurich Switzerland.
JBMR Plus. 2021 Oct 30;5(12):e10567. doi: 10.1002/jbm4.10567. eCollection 2021 Dec.
In this review we summarize the impact of bolus versus daily dosing of vitamin D on 25(OH)D and 1,25(OH)D levels, as well as on key countervailing factors that block vitamin D functions at the cellular level. Further, we discuss the role of bolus versus daily dosing of vitamin D for several health outcomes, including respiratory infections and coronavirus disease 2019 (COVID-19), rickets, falls and fractures, any cancer, and cancer-related mortality. This discussion appears timely because bolus doses continue to be tested for various disease outcomes despite a growing amount of evidence suggesting lack of efficacy or even detrimental effects of bolus dosing of vitamin D for outcomes where daily dosing at modest levels was effective in the vitamin D deficient. As a result, these discordant results may bias health recommendations for vitamin D if the recommendations are based on meta-analyses combining both daily and bolus dosing trials. © 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
在本综述中,我们总结了大剂量维生素D与每日服用维生素D对25(OH)D和1,25(OH)D水平的影响,以及对在细胞水平上阻断维生素D功能的关键抵消因素的影响。此外,我们讨论了大剂量维生素D与每日服用维生素D在多种健康结局中的作用,包括呼吸道感染和2019冠状病毒病(COVID-19)、佝偻病、跌倒和骨折、任何癌症以及癌症相关死亡率。这一讨论显得很及时,因为尽管越来越多的证据表明,对于维生素D缺乏者,适度水平的每日服用维生素D对某些结局有效,但大剂量维生素D仍在针对各种疾病结局进行测试。因此,如果基于综合每日和大剂量给药试验的荟萃分析给出维生素D的健康建议,这些不一致的结果可能会使建议产生偏差。© 2021作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。